Abstract
Treatment of enteropathy in diabetics is demanding, and should focus on both prevention of diabetic gastrointestinal complications and treatment. Up to now, most of the available treatment has been focused on symptom relief, while the preventive strategies are mostly still undergoing research. The most important factor in treatment and prevention of this condition remains a proper level of glycemic control. Several preventive strategies or preventive approaches have been considered and investigated in recent years, such as improvement of nutritional and psychological status, but with no final conclusion. Some new drugs and therapeutic approaches have also emerged recently, with the potential for improving motility or other diabetes-related gastrointestinal symptoms. As celiac disease, like autoimmune enteropathy, occurs in patients with T1D with significantly higher prevalence than in the general population, screening and treatment in diabetics is recommended. The only effective therapy for celiac disease is a life-long gluten-free diet. The combination of gluten-free diet and diabetic diet is sometimes very complicated, and extensive support by a dietitian is mandatory.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Faria M, Pavin EJ, Parisi MC, Lorena SL, Brunetto SQ, Ramos CD, et al. Delayed small intestinal transit in patients with long-standing type 1 diabetes mellitus: investigation of the relationships with clinical features, gastric emptying, psychological distress, and nutritional parameters. Diabetes Technol Ther. 2013;15(1):32.
Sadik R, Abrahamsson H, Stotzer PO. Gender differences in gut transit shown with a newly developed radiological procedure. Scand J Gastroenterol. 2003;38:36–42.
Sadiya A. Nutritional therapy for the management of diabetic gastroparesis: clinical review. Diabetes Metab Syndr Obes. 2012;5:329–35.
Semenkovich K, Brown ME, Svrakic DM, Lustman PJ. Depression in type 2 diabetes mellitus: prevalence, impact, and treatment. Drugs. 2015;75(6):577–87.
Smith KJ, Béland M, Clyde M, Gariépy G, Pagé V, Badawi G, et al. Association of diabetes with anxiety: a systematic review and meta-analysis. J Psychosom Res. 2013;74(2):89–99.
Anitha M, Gondha C, Sutliff R, Parsadanian A, Mwangi S, Sitaraman SV, et al. GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway. J Clin Invest. 2006;116(2):344–56.
Shotton HR, Broadbent S, Lincoln J. Prevention and partial reversal of diabetes-induced changes in enteric nerves of the rat ileum by combined treatment with alpha-lipoic acid and evening primrose oil. Auton Neurosci. 2004;111(1):57–65.
Pereira RV, Tronchini EA, Tashima CM, Alves EP, Lima MM, Zanoni JN. L-glutamine supplementation prevents myenteric neuron loss and has gliatrophic effects in the ileum of diabetic rats. Dig Dis Sci. 2011;56(12):3507–16.
Zanoni JN, Tronchini EA, Moure SA, Souza ID. Effects of L-glutamine supplementation on the myenteric neurons from the duodenum and cecum of diabetic rats. Arq Gastroenterol. 2011;48(1):66–71.
De Freitas P, Natali MR, Pereira RV, Miranda Neto MH, Zanoni JN. Myenteric neurons and intestinal mucosa of diabetic rats after ascorbic acid supplementation. World J Gastroenterol. 2008;14(42):6518–24.
Shotton HR, Adams A, Lincoln J. Effect of aminoguanidine treatment on diabetes-induced changes in the myenteric plexus of rat ileum. Auton Neurosci. 2007;132(1–2):16–26.
da Silva GG, Zanoni JN, Buttow NC. Neuroprotective action of Ginkgo biloba on the enteric nervous system of diabetic rats. World J Gastroenterol. 2011;17(7):898–905.
Zhao M, Liao D, Zhao J. Diabetes-induced mechanophysiological changes in the small intestine and colon. World J Diabetes. 2017;8(6):249–69.
Krishnan B, Babu S, Walker J, Walker AB, Pappachan JM. Gastrointestinal complications of diabetes mellitus. World J Diabetes. 2013;4(3):51–63.
Samsom M, Verhagen MAMT. Intestinal function. In: Horowitz M, Samsom M, editors. Gastrointestinal function in diabetes mellitus. Wiley: Chichester; 2004.
Pimentel M. Review of rifaximin as treatment for SIBO and IBS. Expert Opin Investig Drugs. 2009;18:349–58.
Evers J, Jones JFX, O’Connell PR. Systematic review of animal models used in research of origins and treatments of fecal incontinence. Dis Colon Rectum. 2017;60(6):614–26.
Collier A, McLaren J, Godwin J, Bal A. Is Clostridium difficile associated with the ‘4C’ antibiotics? A retrospective observational study in diabetic foot ulcer patients. Int J Clin Pract. 2014;68(5):628–32.
Murao S, Hosokawa H. Serotonin 5-HT3 receptor antagonist for treatment of severe diabetic diarrhea. Diabetes Care. 2010;33(3):e38. https://doi.org/10.2337/dc09-2131.
Quigley EM. Cisapride: what can we learn from the rise and fall of a prokinetic? J Dig Dis. 2011;12:147–56.
De La Luz Nieto M, Wu JM, Matthews C, Whitehead WE, Markland AD. Factors associated with fecal incontinence in a nationally representative sample of diabetic women. Int Urogynecol J. 2015;26(10):1483–8.
Stevens JE, Jones KL, Rayner CK, Horowitz M. Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives. Expert Opin Pharmacother. 2013;14(9):1171–86.
Gatopoulou A, Papanas N, Maltezos E. Diabetic gastrointestinal autonomic neuropathy: current status and new achievements for everyday clinical practice. Eur J Intern Med. 2012;23(6):499–505.
Song GQ, Sun Y, Foreman RD, Chen JD. Therapeutic potential of spinal cord stimulation for gastrointestinal motility disorders: a preliminary rodent study. Neurogastroenterol Motil. 2014;26(3):377–84.
Camarca ME, Mozzillo E, Nugnes R, Zito E, Falco M, Fattorusso V, et al. Celiac disease in type 1 diabetes mellitus. Ital J Pediatr. 2012;38:10.
Rubio-Tapia A, Hill ID, Kelly CP, et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656–76. Quiz 677.
Ludvigsson JF, Bai JC, Biagi F, Card TR, Ciacci C, Ciclitira PJ, et al. Diagnosis and management of adult celiac disease: guidelines from the British Society of Gastroenterology. Gut. 2014;63:1210–28.
Sadiq Butt M, Tahir-Nade em M, Khan MK, et al. Oat: unique among the cereals. Eur J Nutr. 2008;47:68–79.
Welstead L. The gluten-free diet in the 3rd millennium: rules, risks and opportunities. Diseases. 2015;3:136–49.
Marchese A, Lovati E, Biagi F, Corazza GR. Coeliac disease and type 1 diabetes mellitus: epidemiology, clinical implications and effects of gluten-free diet. Endocrine. 2013;43:1–2.
Parzanese I, Qehajaj D, Patrinicola F, Aralica M, Chiriva-UInternati M, Stifter S, et al. From pathophysiology to treatment. World J Gastrointest Pathophysiol. 2017;15(8):27–38.
Ozgör B, Selimoglu MA. Coeliac disease and reproductive disorders. Scand J Gastroenterol. 2010;45:395–402.
Kelly CP, Bai JC, Liu E. Advances in diagnosis and management of celiac disease. Gastroenterology. 2015;148(6):1175–86.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Jelaković, M., Čuković-Čavka, S. (2018). Treatment. In: Duvnjak, M., Smirčić-Duvnjak, L. (eds) Gastrointestinal Complications of Diabetes . Clinical Gastroenterology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-75856-5_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-75856-5_11
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-75855-8
Online ISBN: 978-3-319-75856-5
eBook Packages: MedicineMedicine (R0)